WILMINGTON,Ludo Reynders returned to his CEO duties at aaiPharma on Monday after a two-week bout with pneumonia.

The company announced his return after the markets closed.

“The last two weeks have been challenging and I am pleased to be able to return to my duties,” Reynders said in a statement. “It was good to see the commitment of our management team as they continued the execution of our corporate recovery plan.”

Financial reviews continue at the firm.

aaiPharma: www.aaiPharma.com